SLC27A5 and metabolic dysfunction-associated steatotic liver disease: Previous study has also suggested that hepatic FATP5 expression is related to histological progression and loss of hepatic fat in Nonalcoholic Fatty Liver Disease (NAFLD) patients (Enooku et al., 2020), indicating that down-regulated expression of hepatic FATP5 in NAFLD is related to histological progression, and may be associated with hepatic fat loss during NASH progression to cirrhosis.